prednisolone has been researched along with Afibrinogenemia in 7 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Afibrinogenemia: A deficiency or absence of FIBRINOGEN in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"We report here a patient with acute lymphoblastic leukemia (ALL) in whom hypofibrinogenemia developed during chemotherapy." | 2.38 | [Transient hypofibrinogenemia induced by prednisolone in a case of acute lymphoblastic leukemia]. ( Baba, Y; Fujieda, H; Hojo, H; Ohyashiki, JH; Ohyashiki, K; Toyama, K, 1989) |
"A case of a girl with Langerhans cell histiocytosis who had hypofibrinogenemia during etoposide (VP-16) and prednisolone therapy is described." | 1.29 | Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy. ( Fujimoto, J; Meguro, T; Miura, T; Nakamura, M; Tsunematsu, Y; Yamada, K, 1993) |
"A 38-year-old female with acute lymphoblastic leukemia developed monoplegia of the left upper extremity following chemotherapy for remission induction consisting of vincristine, prednisolone, cyclophosphamide, adriamycin and methotrexate." | 1.28 | [Transient dysfibrinogenemia and cerebral thrombosis following remission induction therapy for acute lymphoblastic leukemia]. ( Harada, M; Hayashi, S; Kubota, T; Nagafuchi, S; Niho, Y; Ohtsuka, T; Okamura, T; Shibuya, T, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanada, T | 1 |
Nakahara, S | 1 |
Takita, H | 1 |
Oshima, M | 1 |
Miura, T | 1 |
Nakamura, M | 1 |
Tsunematsu, Y | 1 |
Fujimoto, J | 1 |
Meguro, T | 1 |
Yamada, K | 1 |
Yokose, N | 1 |
Ogata, K | 1 |
Nakamura, K | 1 |
Kamikubo, K | 1 |
Tamura, H | 1 |
An, E | 1 |
Dan, K | 1 |
Nomura, T | 1 |
Presterl, E | 1 |
Wagner, L | 1 |
Base, W | 1 |
Maak, B | 1 |
Meyer, M | 1 |
Dietze, H | 1 |
Kubota, T | 1 |
Okamura, T | 1 |
Hayashi, S | 1 |
Nagafuchi, S | 1 |
Ohtsuka, T | 1 |
Shibuya, T | 1 |
Harada, M | 1 |
Niho, Y | 1 |
Fujieda, H | 1 |
Hojo, H | 1 |
Ohyashiki, JH | 1 |
Ohyashiki, K | 1 |
Toyama, K | 1 |
Baba, Y | 1 |
1 review available for prednisolone and Afibrinogenemia
Article | Year |
---|---|
[Transient hypofibrinogenemia induced by prednisolone in a case of acute lymphoblastic leukemia].
Topics: Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Fem | 1989 |
6 other studies available for prednisolone and Afibrinogenemia
Article | Year |
---|---|
111In-labelled platelet scintigraphy in Kasabach-Merritt syndrome.
Topics: Afibrinogenemia; Blood Platelets; Female; Head and Neck Neoplasms; Hemangioma; Humans; Indium; Infan | 1984 |
Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
Topics: Afibrinogenemia; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Lang | 1993 |
Hypofibrinogenemia induced by prednisolone therapy in a patient with chronic lymphocytic leukemia complicated with autoimmune hemolytic anemia.
Topics: Afibrinogenemia; Anemia, Hemolytic, Autoimmune; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male | 1997 |
Hypofibrinogenemia due to fibrin formation in subserosal type eosinophilic gastroenteropathy.
Topics: Adult; Afibrinogenemia; Eosinophilia; Female; Fibrin; Gastrointestinal Diseases; Humans; Prednisolon | 1992 |
[Acquired dysfibrinogenemia in a child in the course of a liver disease].
Topics: Adolescent; Afibrinogenemia; Autoimmune Diseases; Blood Coagulation Tests; Fibrinogen; Humans; Liver | 1990 |
[Transient dysfibrinogenemia and cerebral thrombosis following remission induction therapy for acute lymphoblastic leukemia].
Topics: Adult; Afibrinogenemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubici | 1990 |